<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00002149</url>
  </required_header>
  <id_info>
    <org_study_id>243A</org_study_id>
    <nct_id>NCT00002149</nct_id>
  </id_info>
  <brief_title>Acupuncture and Herbal Treatment of Chronic HIV Sinusitis</brief_title>
  <official_title>Acupuncture and Herbal Treatment of Chronic HIV Sinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Immune Enhancement Project</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NIH AIDS Clinical Trials Information Service</source>
  <brief_summary>
    <textblock>
      To compare Traditional Chinese Medicine versus standard antibiotic therapy consisting of&#xD;
      pseudoephedrine ( Sudafed ) plus amoxicillin / clavulanate potassium combination ( Augmentin&#xD;
      ) in reducing symptoms and recurrence of acute HIV-related sinusitis.&#xD;
&#xD;
      Chronic sinusitis in HIV-infected individuals is a recurrent and persistent infection with&#xD;
      potentially serious complications: it can exacerbate pulmonary disease, cause recurrences of&#xD;
      life-threatening sepsis, and progress to central nervous system involvement. Symptoms of&#xD;
      sinusitis in HIV patients are often refractory to aggressive Western medical management, and&#xD;
      antibiotic intolerance can occur. Traditional Chinese Medicine consisting of acupuncture and&#xD;
      herbal treatment may provide a low-risk, low-cost alternative to conventional antibiotic&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic sinusitis in HIV-infected individuals is a recurrent and persistent infection with&#xD;
      potentially serious complications: it can exacerbate pulmonary disease, cause recurrences of&#xD;
      life-threatening sepsis, and progress to central nervous system involvement. Symptoms of&#xD;
      sinusitis in HIV patients are often refractory to aggressive Western medical management, and&#xD;
      antibiotic intolerance can occur. Traditional Chinese Medicine consisting of acupuncture and&#xD;
      herbal treatment may provide a low-risk, low-cost alternative to conventional antibiotic&#xD;
      therapy.&#xD;
&#xD;
      Patients are randomized to receive either Traditional Chinese Medicine (acupuncture and&#xD;
      herbal treatment) or conventional antibiotic therapy (Sudafed and Augmentin). Treatment&#xD;
      continues for 8 weeks, followed by a 4 week washout, with final follow-up at week 12.&#xD;
      Patients must undergo endoscopic nasal exam and CT scan of paranasal sinus prior to study&#xD;
      entry and at week 12.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>40</enrollment>
  <condition>HIV Infections</condition>
  <condition>Sinusitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clavulanate potassium</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pseudoephedrine hydrochloride</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin trihydrate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        Concurrent Medication:&#xD;
&#xD;
        Allowed:&#xD;
&#xD;
          -  Antiviral medication.&#xD;
&#xD;
        Patients must have:&#xD;
&#xD;
          -  HIV infection.&#xD;
&#xD;
          -  CD4 count &gt;= 50 cells/mm3.&#xD;
&#xD;
          -  Recurrent sinusitis.&#xD;
&#xD;
          -  No active opportunistic infection.&#xD;
&#xD;
          -  No disease progression.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Co-existing Condition:&#xD;
&#xD;
        Patients with the following symptoms or conditions are excluded:&#xD;
&#xD;
          -  Active infection with fever &gt; 102 F.&#xD;
&#xD;
          -  Neurological symptoms such as epidural abscess, subdural hematoma, meningitis, and&#xD;
             dementia.&#xD;
&#xD;
          -  Malignant neoplasm of nasal passages.&#xD;
&#xD;
          -  Not expected to remain clinically stable for the next 6 months.&#xD;
&#xD;
          -  Inability to comply with protocol requirements.&#xD;
&#xD;
          -  Malabsorption or inability to take oral medication.&#xD;
&#xD;
          -  Concurrent participation on another study where antibiotics will be used.&#xD;
&#xD;
        Concurrent Medication:&#xD;
&#xD;
        Excluded:&#xD;
&#xD;
          -  Antibiotics other than Septra.&#xD;
&#xD;
        Concurrent Treatment:&#xD;
&#xD;
        Excluded:&#xD;
&#xD;
          -  Chinese herbal medicine or acupuncture unless on that study arm.&#xD;
&#xD;
          -  Surgical intervention that has abated symptoms.&#xD;
&#xD;
        Patients with the following prior condition are excluded:&#xD;
&#xD;
        History of allergic reaction to the study antibiotics.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Immune Enhancement Project</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 1997</verification_date>
  <study_first_submitted>November 2, 1999</study_first_submitted>
  <study_first_submitted_qc>August 30, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2001</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>AIDS-Related Opportunistic Infections</keyword>
  <keyword>Drug Therapy, Combination</keyword>
  <keyword>Acquired Immunodeficiency Syndrome</keyword>
  <keyword>AIDS-Related Complex</keyword>
  <keyword>Sinusitis</keyword>
  <keyword>Ephedrine</keyword>
  <keyword>Acupuncture Therapy</keyword>
  <keyword>Drugs, Chinese Herbal</keyword>
  <keyword>Medicine, Chinese Traditional</keyword>
  <keyword>Drug Combinations</keyword>
  <keyword>Antibiotics, Combined</keyword>
  <keyword>Amoxicillin-Potassium Clavulanate Combination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Pseudoephedrine</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

